Website
N/ATelephone
61.3.9087.1598
Address
Level 4 100 Albert Road South Melbourne, Victoria (VIC) 3205
Description
Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. It manages the provision of diagnostics goods and services. It operates through the United States and Australia geographical segments. The company was founded in 2015 and is headquartered in South Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.17
Trade Value (12mth)
AU$167,880.00
1 week
15.87%
1 month
-10.98%
YTD
52.08%
1 year
55.32%
All time high
1.39229
EPS 3 yr Growth
-31.600%
EBITDA Margin
-61.70%
Operating Cashflow
-$14m
Free Cash Flow Return
-47.00%
ROIC
-43.70%
Interest Coverage
-2.70
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
309m
HALO Sector
Healthcare
Next Company Report Date
20-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 January 22 |
Change in Reporting Currency
×
Change in Reporting Currency |
31 January 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 September 22 |
Notification regarding unquoted securities - LDX
×
Notification regarding unquoted securities - LDX |
30 October 23 |
LDX Raises A$2.65 Million in Successful Placement
×
LDX Raises A$2.65 Million in Successful Placement |
30 October 23 |
Proposed issue of securities - LDX
×
Proposed issue of securities - LDX |
30 November 22 |
AGM Chair Address & Presentation
×
AGM Chair Address & Presentation |
30 November 22 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 March 23 |
Change in substantial holding from RYD
×
Change in substantial holding from RYD |
30 June 22 |
Change of Director's Interest Notice - SL
×
Change of Director's Interest Notice - SL |
30 June 22 |
CR
×
CR |
30 June 22 |
Change of Director's Interest Notice - CR
×
Change of Director's Interest Notice - CR |
30 June 22 |
Change of Director's Interest Notice - BLG
×
Change of Director's Interest Notice - BLG |
30 June 22 |
Appendix 2A
×
Appendix 2A |
30 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
30 August 23 |
FY23 Appendix 4E
×
FY23 Appendix 4E |
30 August 23 |
FY23 Annual Report
×
FY23 Annual Report |
30 August 23 |
FY23 Full Year Results Announcement
×
FY23 Full Year Results Announcement |
30 August 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 August 23 |
FY23 Full Year Results Investor Presentation
×
FY23 Full Year Results Investor Presentation |
30 August 23 |
Change in substantial holding
×
Change in substantial holding |
30 August 22 |
Change in substantial holding
×
Change in substantial holding |
30 August 21 |
FY21 Annual Report
×
FY21 Annual Report |
30 August 21 |
FY21 Full Year Results Investor Presentation
×
FY21 Full Year Results Investor Presentation |
29 November 22 |
Appendix 2A
×
Appendix 2A |
29 July 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
29 August 23 |
Lumos Diagnostics FY2023 Full Year Results Webinar
×
Lumos Diagnostics FY2023 Full Year Results Webinar |
29 April 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.